Orchard Therapeutics (ORTX)
NASDAQ: ORTX
· Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM
Orchard Therapeutics Revenue
Orchard Therapeutics reported an annual revenue of $6.99M, reflecting a 1346.38% growth. For the quarter ending September 30, 2023, Orchard Therapeutics generated $6.3M in revenue.
Revenue (ttm)
6.99M
Revenue Growth
1346.38%
Price / Sales Ratio
6.78
Revenue / Employee
42.08K
Employees
166
Market Cap
380.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 6.99M | +1346.38% |
| Dec 31, 2021 | 483K | -81.39% |
| Dec 31, 2020 | 2.6M | +3.26% |
| Dec 31, 2019 | 2.51M | +21.05% |
| Dec 31, 2018 | 2.08M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |